Document text
Principal Investigator: Benjamin Elison Gewurz
Organization: BRIGHAM AND WOMEN'S HOSPITAL
Fiscal Year: 2024
Award: $20,250
Funding agency: National Cancer Institute
ABSTRACT
This conference grant application requests funds to help support the 2024 International Conference on EBV &
KSHV. The conference will be held at the Boston Park Plaza Hotel. This joint conference is unique and
innovative in that it combines the International Workshop on Kaposi’s Sarcoma-Associated Herpesvirus
(KSHV) and Related Agents and the International Symposium on Epstein-Barr Virus (EBV) and Associated
Diseases. The funds will be used to reduce the conference registration costs for outstanding pre- and post-
doctoral trainees, historically under-represented minorities including those from underserved areas. The goals
of these meetings are consistent with the mission statements of the NIH, NCI, NIAID, and NIDCR, namely, to
advance and promote the pace of research on infections associated with human cancer and other diseases,
including in the setting of HIV-AIDS. The joint EBV & KSHV Meeting will be held June 29th – July 3rd, 2024. All
remaining costs for these conferences will be raised from registration fees paid by the conferees and
contributions, foundations, and pharmaceutical and biotechnology companies. The main focus of the EBV &
KSHV meeting is on the biology of oncogenic herpesviruses and associated human diseases, with specific
emphasis on viral pathogenesis, viral latency and reactivation, viral gene expression and replication, host
responses to infection and autoimmunity, epidemiology, vaccine development, and therapeutic intervention. In
addition to EBV and KSHV, studies related to Herpesvirus saimiri, murine herpesvirus-68, rhesus rhadinovirus,
and rhesus lymphocryptovirus will be presented. The combined EBV/KSHV conference has not been held
since 2018 and will optimize the potential for synergistic interactions among the conferees and the potential for
new collaborations.
Terms: <21+ years old><AIDS/HIV><Adult><Adult Human><Africa><American><Applications Grants><Asia><Autoimmune Status><Autoimmunity><Biology><Biotech><Biotechnology><Boston><Burkitt Herpesvirus><Burkitt Lymphoma Virus><Cancer Treatment><Cancers><Clinical><Collaborations><Complex><Data><Development><Discipline><Disease><Disorder><EB virus><EBV><Educational workshop><Epidemiology><Epstein Barr Virus><Europe><Fees><Fostering><Foundations><Funding><Gastric Carcinoma><Gene Expression><Germinoblastic Sarcoma><Germinoblastoma><Goals><Grant Proposals><HHV-4><HHV-8><HHV4><HHV8><HIV/AIDS><Herpesviridae><Herpesvirus 2 (gamma), Saimirine><Herpesvirus saimiri><Herpesviruses><Hodgkin Disease><Hodgkin Disorder><Hodgkin lymphoma><Hodgkin's><Hodgkin's Lymphoma><Hodgkin's disease><Hodgkins lymphoma><Human><Human Herpesvirus 4><Human Herpesvirus 8><Immune response><Immunological response><Individual><Infection><Infectious Agent><Infectious Mononucleosis Virus><International><Investigators><Joints><KSHV><Kaposi Sarcoma><Kaposi Sarcoma-Associated Herpes Virus><Kaposi Sarcoma-Associated Herpesvirus><Kaposi sarcoma associated virus><Kaposi sarcoma herpes virus><Kaposi's Sarcoma><Kaposi's sarcoma (KS)-associated herpesvirus><Knowledge><Lymphocryptovirus><Lymphoma><Malignant Lymphogranuloma><Malignant Lymphoma><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Tumor><Mission><Modern Man><Mouse herpesvirus strain 68><Multicentric Angiofollicular Lymphoid Hyperplasia><Multicentric Castleman's Disease><Multiple Hemorrhagic Sarcoma><Murid herpesvirus 4><Murine herpesvirus 68><NIAID><NIDCR><NIDR><NIH><NIH RFA><Nasopharyngeal Carcinoma><Nasopharynx Carcinoma><National Institute of Allergy and Infectious Disease><National Institute of Dental Research><National Institute of Dental and Craniofacial Research><National Institutes of Health><North America><Ohio><Oncogenic><Oral><Participant><Pathogenesis><Patients><Pharmaceutical Agent><Pharmaceuticals><Pharmacologic Substance><Pharmacological Substance><Play><Pleural Effusion><Pleural effusion disorder><Postdoc><Postdoctoral Fellow><Preventative strategy><Prevention strategy><Preventive strategy><Reagent><Request for Applications><Research><Research Associate><Research Personnel><Researchers><Reticulolymphosarcoma><Rhadinovirus><Rhesus><Role><Rotation><Saimiriine Herpesvirus 2><Saimirine Herpesvirus 2><Site><Societies><Stomach Carcinoma><Therapeutic Intervention><Time><Travel><Underrepresented Ethnic Minority><Underrepresented Minority><United States National Institutes of Health><Viral Cancer><Viral Diseases><Viral Genes><Viral Latency><Viral Pathogenesis><Virus><Virus Diseases><Virus Latency><Virus-HHV8><Virus-Related Malignancy><Virus-Related Malignant Neoplasm><Workshop><adulthood><anti-cancer therapy><biopharmaceutical company><biopharmaceutical industry><cancer therapy><cancer-directed therapy><cofactor><conference><convention><cost><data exchange><data transfer><data transmission><develop a vaccine><develop vaccines><development of a vaccine><developmental><epidemiologic><epidemiological><gamma-herpesvirus><gammaherpesvirus><herpes virus><host response><human disease><immune system response><immunization strategy><immunoresponse><infectious organism><innovate><innovation><innovative><intervention therapy><kaposi's sarcoma herpesvirus><kaposi's sarcoma-associated human herpesvirus><latency/reactivation><malignancy><meeting><meetings><member><multicastleman's diseases><neoplasm/cancer><new therapeutic approach><new therapeutic intervention><new therapeutic strategies><new therapy approaches><new treatment approach><new treatment strategy><new vaccines><next generation vaccines><novel><novel therapeutic approach><novel therapeutic intervention><novel therapeutic strategies><novel therapy approach><novel vaccines><pharmaceutical><pleural cavity effusion><post-doc><post-doctoral><post-doctoral trainee><post-transplant><post-transplantation><posters><posttransplant><posttransplantation><pre-doc><pre-doctoral><predoctoral><reactivation from latency><research associates><social role><summit><symposia><symposium><under served area><under served geographic area><under served location><under served region><under-representation of minorities><under-represented minority><underrepresentation of minorities><underserved area><underserved geographic area><underserved location><underserved region><vaccination strategy><vaccine development><viral associated cancer><viral associated malignancy><viral associated malignant neoplasm><viral induced cancer><viral induced malignancy><viral induced malignant neoplasm><viral infection><viral related cancer><viral related malignancy><viral related malignant neoplasm><virology><virus associated cancer><virus associated malignancy><virus associated malignant neoplasm><virus induced cancer><virus induced malignancy><virus induced malignant neoplasm><virus infection><virus pathogenesis><virus related cancer><virus-induced disease><γ-herpesvirus>